Search Results

Keywords: sativex

Growing Momentum: Italy

Milestones in the Medical Cannabis Program Doctors could first recommend cannabis-derived medicine in 2006, but significant quantities weren’t prescribed until 2014.   Key Laws and Regulations Law: April 8, 1998, n. 94 Ordinance: July 18, 2006 Ministerial Decree: April 18, 2007 Ministerial Decree: Jan. 23, 2013   Market Data No centralized registry of patients exists. […]

Read More

Growing Momentum: Brazil

Milestones in the Medical Cannabis Program The National Sanitary Surveillance Agency regulated “compassionate use” imports in 2015.   Key Laws and Regulations RDC No. 17/2015 Portaria 344/1998   Market Data Since 2014, almost 10,000 authorizations were granted to individual patients, allowing them to import medical cannabis on a case-by-case basis, each for a period of […]

Read More

Barbados procuring medical cannabis for first imports in April

The Barbados Drug Service is inviting companies to submit applications to supply the nation with approved medical cannabinoid products starting April 2020 and lasting through March 31, 2022. The requested products are not legally available in the eastern Caribbean nation at this time. Separately, a bill was introduced in the country’s parliament this week to […]

Read More

Brazilian health regulators mull plan for cannabis cultivation and products, but proposal draws opposition

Brazilian health regulators are weighing a landmark plan to permit the domestic cultivation of marijuana and the registration of medical cannabis products that have not yet completed clinical trials, a move that would open a potentially huge market to MJ companies from around the globe. But the proposed rules have encountered stiff opposition from a […]

Read More

GW Pharma’s cannabis drug OK’d by European Medicines Agency panel

GW Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) recommended approval of the British company’s cannabis-based medicine Epidiolex. The CHMP is responsible for preparing the European Medicines Agency (EMA)’s opinions on questions related to the marketing of human medicines. The CHMP opinion was adopted July 25, and the final decision now rests […]

Read More

South Korean medical cannabinoid imports surpass 300 units since law passed

South Korea saw just over 300 approved imports of cannabinoid-based medicines in the first few months of the country’s newly regulated medical cannabis program, a volume that underwhelmed local experts who expected demand to be much higher. Almost all the medical cannabis prescriptions were for pure CBD oil. Through July 19, exactly 300 prescriptions had been […]

Read More

Breakthrough in Brazil: Regulators eye domestic cannabis cultivation, creation of product registration plan

Brazil could become the latest country to regulate the domestic cultivation of medical cannabis, according to the government body responsible for regulating marijuana – a move that will have major implications for the industry when the rules take effect. At a public meeting last week, the National Sanitary Surveillance Agency (ANVISA) collegiate directors approved two draft […]

Read More

Germany’s medical cannabis market prioritizes efficacy over unfettered access

Germany may be the largest and fastest-growing medical cannabis market in Europe, but signs are emerging from medical and regulatory circles that should serve as a warning to marijuana companies planning to commercialize medicines without conclusive clinical trials. In fact, businesses based on science and efficacy may see a competitive advantage in Germany in the […]

Read More